SPONSOR
Erasmus Medical Center
Total Trials
15
Recruiting
15
Phases
Phase 2
Conditions studied: Chronic Kidney Disease Stage 3CardiotoxicityBreast CancerEarly DischargeTelemedicineVirtual ClinicHospital at HomeFeasibility StudiesCancerEmergencies
Erasmus Medical Center is a clinical research sponsor with 15 registered studies on ClinicalTrials.gov, of which 15 are actively recruiting participants. Research covers conditions including Chronic Kidney Disease Stage 3, Cardiotoxicity, Breast Cancer, Early Discharge.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Erasmus Medical Center
How many clinical trials has Erasmus Medical Center sponsored?
ClinicalMetric currently tracks 15 clinical trials sponsored by Erasmus Medical Center, of which 15 are actively recruiting participants. These trials cover conditions including Chronic Kidney Disease Stage 3, Cardiotoxicity, Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Erasmus Medical Center research focus on?
Erasmus Medical Center clinical trials span Chronic Kidney Disease Stage 3, Cardiotoxicity, Breast Cancer, Early Discharge, Telemedicine, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Erasmus Medical Center clinical trial?
To participate in a Erasmus Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Erasmus Medical Center trials with current recruitment status updated daily.
Clinical Trials by Erasmus Medical Center
NCT06732349
Recruiting
Urinary Tubular Biomarkers for Chronic Kidney Disease
Chronic Kidney Disease Stage 3
NCT06622954
Recruiting
Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients
Cardiotoxicity
NCT06936891
Recruiting
Virtual Ward for Early Discharge in Patients Receiving Inpatient Care
Early Discharge
NCT06680778
Recruiting
Pro-active Monitoring of Vital Signs in Oncology Patients Using a Smartwatch
Cancer
NCT06817330
Recruiting
The Effect of a Music Intervention on Postictal Agitation in Electroconvulsive Therapy Patients
Music Intervention
NCT06438198
Recruiting
Early Switch from Controlled to Assisted Ventilation
Acute Hypoxemic Respiratory Failure
NCT06841692
Recruiting
Diuretic Testing in Chronic Kidney Disease
Kidney Disease, Chronic
NCT06888063 Phase 2
Recruiting
Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery
Intrahepatic Bile Duct Cancer
NCT06883448
Recruiting
Implementation of Home Monitoring in Patients With Pulmonary Fibrosis
Pulmonary Fibrosis
NCT07337057
Recruiting
DEntal implaNt Set: Development and Implementation of a Standardized Outcome Set in Implant Dentistry
Tooth Loss / Rehabilitation
NCT06558487
Recruiting
The Internal Prospective Validation of the Cancer Admission Score (CAS) Prediction Model
Oncology
NCT06944002
Recruiting
Milk Consumption and Blood Microbiome in Healthy Volunteers
Healthy
NCT06546371
Recruiting
Spinal Cord Stimulation for Intractable Mononeuropathy
Mononeuropathies
NCT06785506
Recruiting
Multiple-biomarker Approach for Individualized Treatment of Heart Failure with Preserved Ejection Fraction
Heart Failure with Preserved Ejection Fraction
NCT07513077
Recruiting
Prevention of Noise-Induced Hearing Loss in Primary Education
Effectiveness of Application Education Intervention
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology